back to homepage

World News

Alkermes Gets FDA Approval for Schizophrenia Treatment Aristada

Alkermes (ALKS), a biopharmaceutical company, said Tuesday the U.S. Food and Drug Administration has approved ARISTADA extended-release injectable suspension to treat schizophrenia. The company is preparing to launch the drug

Read More

Biomed Realty Trust Exploring Sale

Biomed Realty Trust (BMR) is trading more than 9% higher in pre-market in reaction to a report from Bloomberg that the company is exploring a sale, and has retained Morgan

Read More

GE Healthcare Commits $300 Mln to Create New Business Unit

GE Healthcare, the healthcare technology division of GE (GE), said it has created a new business unit, Sustainable Healthcare Solutions, that will develop high-value, low-cost technologies and healthcare delivery solutions

Read More